Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

Keyphrases

• West Nile Virus 100%
• Vaccine Antigen 100%
• Mutant Virus 100%
• Non-glycosylated 100%
• Virus 50%
• Flavivirus 50%
• Attenuation 50%
• Non-structural Protein 50%
• Cell Culture 50%
• High Titer 50%
• Ablation 50%
• Neuroinvasiveness 50%
• New York 50%
• Antiviral Drugs 50%
• Lethal Challenge 50%
• Viremia 50%
• Post-infection 50%
• Neutralizing Antibodies 50%
• Arthropod-borne 50%
• Glycosylation Site 50%
• Parental Strain 50%
• Protective Dose 50%
• Plaque Phenotype 50%

Biochemistry, Genetics and Molecular Biology

• West Nile Virus 100%
• Virus Mutant 100%
• Cell Culture 50%
• Flavivirus 50%
• Titer 50%
• Low Drug Dose 50%
• Viremia 50%
• Glycosylation 50%
• Neutralizing Antibody 50%

Immunology and Microbiology

• West Nile Virus 100%
• Virus Mutant 100%
• Flavivirus 50%
• Cell Culture 50%
• Titer 50%
• Neutralizing Antibody 50%
• Viremia 50%
• Low Drug Dose 50%
• Glycosylation 50%